Literature DB >> 20211254

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.

Joost Smolders1, Paul Menheere, Mariëlle Thewissen, Evelyn Peelen, Jan Willem Cohen Tervaert, Raymond Hupperts, Jan Damoiseaux.   

Abstract

Vitamin D is a potent immune modulator in multiple sclerosis (MS), but was primarily identified for its effects on calcium homeostasis. It is uncertain whether these calcaemic functions of vitamin D are critically involved in its immune modulating potential. We earlier reported a correlation between serum 25-hydroxyvitamin D (25(OH)D) levels and regulatory T cell (Treg) function. In the present study, the correlation of serum levels of 1,25-dihydroxyvitamin D (1,25(OH)2D), intact parathyroid hormone (PTH), and total calcium with Treg number and functionality and the proportions of other T helper cell subsets was assessed in 29 relapsing remitting MS patients. In contrast to serum 25(OH)D levels, serum concentrations of neither 1,25(OH)2D, nor PTH and total calcium correlated significantly with Treg function or Th1/Th2 ratio. None of the parameters correlated with the relative and absolute number of Tregs. Interestingly, the serum levels of 1,25(OH)2D correlated positively with the proportion of T helper type 17 (Th17) cells. These results suggest that the serum levels of 1,25(OH)2D, PTH, and total calcium are not critically involved in the correlation between vitamin D status and T cell regulation. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211254     DOI: 10.1016/j.jsbmb.2010.03.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  24 in total

1.  High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells.

Authors:  Barbara Prietl; Gerlies Treiber; Julia K Mader; Evelyne Hoeller; Michael Wolf; Stefan Pilz; Winfried B Graninger; Barbara M Obermayer-Pietsch; Thomas R Pieber
Journal:  Eur J Nutr       Date:  2013-09-03       Impact factor: 5.614

2.  Vitamin D and multiple sclerosis hospital admissions in Scotland.

Authors:  G Disanto; A E Handel; J M Morahan; G C Deluca; S M Kimball; E Hypponen; G Giovannoni; G C Ebers; S V Ramagopalan
Journal:  QJM       Date:  2011-06-29

3.  Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Authors:  Maryam Abbasi; Seyed Massood Nabavi; Seyed Mohammad Fereshtehnejad; Nikan Zerafat Jou; Iman Ansari; Vahid Shayegannejad; Seyed Ehsan Mohammadianinejad; Mahdi Farhoudi; Abbas Noorian; Nazanin Razazian; Mahmoud Abedini; Fardin Faraji
Journal:  Neurol Sci       Date:  2017-08-10       Impact factor: 3.307

4.  Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.

Authors:  Yue Guo; Xiao-Dong Zhuang; Wen-Biao Xian; Ling-Ling Wu; Ze-Na Huang; Xun Hu; Xiang-Song Zhang; Ling Chen; Xin-Xue Liao
Journal:  CNS Neurosci Ther       Date:  2017-06-19       Impact factor: 5.243

Review 5.  T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D.

Authors:  Amolak S Bansal; Frances Henriquez; Nazira Sumar; Sanjeev Patel
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

Review 6.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

7.  The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos).

Authors:  Hamit Yasar Ellidag; Necat Yilmaz; Fatma Kurtulus; Ozgur Aydin; Esin Eren; Ayca Inci; Suleyman Dolu; Fatma Demet Arslan Ince; Özlem Giray; Aylin Yaman
Journal:  Ann Neurosci       Date:  2016-09-09

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Mechanisms underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells.

Authors:  Hong Zhang; David Q Shih; Xiaolan Zhang
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

10.  Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Authors:  Daniel Golan; Basheer Halhal; Lea Glass-Marmor; Elsebeth Staun-Ram; Orit Rozenberg; Idit Lavi; Sara Dishon; Mira Barak; Sophia Ish-Shalom; Ariel Miller
Journal:  BMC Neurol       Date:  2013-06-14       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.